BRIEF

on LNA SANTE (EPA:LNA)

LNA Santé Reports 2024 Annual Results: Targets Achieved Amidst Challenges

Stock price chart of LNA SANTE (EPA:LNA) showing fluctuations.

LNA Santé has reported its 2024 annual results, showcasing a year of met targets amidst a challenging economic environment. The company's operating sales reached €793.9 million, marking a 6.7% organic growth. Operating EBITDA increased by 2.4% to €146.4 million, while net operating profit rose by 7.7% to €29.7 million.

The company's real estate segment saw a recovery in the last quarter of 2024, with expectations for continued improvement in 2025. Total net financial debt stood at €377.7 million, a 3% increase from the previous year, yet operating debt was reduced by 11% to €111.7 million.

LNA Santé aims to continue its growth trajectory into 2025, targeting operating sales of €845 million, indicating a 6% rise. Strategic plans include targeted acquisitions and real estate developments.

The company maintains a solid financial structure, emphasizing its strategic independence and ongoing commitment to addressing healthcare needs.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all LNA SANTE news